NCT01385800View on ClinicalTrials.gov

ToleroMune Grass Exposure Unit Study

PHASE2CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Grass AllergyRhinoconjunctivitis
Interventions
BIOLOGICAL

ToleroMune Grass

Intradermal injection 1 x 8 administrations 2 weeks apart

BIOLOGICAL

Placebo

Intradermal injection 1 x 8 administrations 2 weeks apart

Trial Locations (1)

K7L 2V7

Kingston General Hospital, Kingston

Sponsors
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Pharm-Olam International

INDUSTRY

lead

Circassia Limited

INDUSTRY

NCT01385800 - ToleroMune Grass Exposure Unit Study | Biotech Hunter | Biotech Hunter